Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the area... Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). 詳細を表示
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference PR Newswire DUBLIN, Dec. 17, 2024 DUBLIN, Dec. 17, 2024 /PRNewswire/ -- Theravance...
Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Nov. 20, 2024 DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.54 | -5.49898167006 | 9.82 | 9.91 | 9.23 | 131326 | 9.42934902 | CS |
4 | -0.53 | -5.40265035678 | 9.81 | 10.25 | 9.23 | 175218 | 9.77677884 | CS |
12 | 1.19 | 14.7095179234 | 8.09 | 10.26 | 8.07 | 187094 | 9.34364239 | CS |
26 | 1.03 | 12.4848484848 | 8.25 | 10.42 | 7.44 | 274287 | 8.79357732 | CS |
52 | -2.39 | -20.4798628963 | 11.67 | 11.71 | 7.44 | 321640 | 8.99822778 | CS |
156 | -1.9 | -16.9946332737 | 11.18 | 13.17 | 7.44 | 560267 | 9.7997444 | CS |
260 | -15.05 | -61.8577887382 | 24.33 | 31.54 | 6.1 | 552699 | 11.91408364 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約